Earth Life Scien Financials
This page shows Earth Life Scien (CLTS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Earth Life Scien passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Earth Life Scien generates $0.01 in operating cash flow (-$16K OCF vs -$1.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earth Life Scien reported -$1.6M in net income in fiscal year 2021. This represents an increase of 13.3% from the prior year.
Earth Life Scien had 961M shares outstanding in fiscal year 2021. This represents an increase of 106.7% from the prior year.
CLTS Income Statement
| Metric | Q3'22 | Q2'22 | Q1'22 | Q3'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $11K+819.8% | $1K-45.5% | $2K | N/A | $9K+193.7% | $3K+3.0% | $3K | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $2K-49.0% | $5K-10.0% | $5K | N/A | $6K+1.3% | $6K+11.7% | $5K | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$21K+93.5% | -$322K-799.5% | -$36K | N/A | -$22K-103.8% | -$11K+99.3% | -$1.5M | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CLTS Balance Sheet
| Metric | Q3'22 | Q2'22 | Q1'22 | Q3'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.4M0.0% | $4.4M0.0% | $4.4M0.0% | $4.4M+2400.9% | $177K-1.7% | $180K0.0% | $180K+2.3% | $176K |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | $4K-97.7% | $176K |
| Cash & Equivalents | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $411K+5.4% | $390K-4.6% | $409K+9.6% | $373K-0.5% | $375K+5.5% | $355K+3.2% | $344K-8.9% | $378K |
| Current Liabilities | $259K+16.4% | $223K+27.3% | $175K | N/A | N/A | N/A | $344K-8.9% | $378K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $4.0M-0.5% | $4.0M+0.5% | $4.0M-0.9% | $4.1M+2150.4% | -$198K-12.8% | -$175K-6.7% | -$164K+18.6% | -$202K |
| Retained Earnings | -$19.1M-0.1% | -$19.1M-1.7% | -$18.7M-0.2% | -$18.7M-0.1% | -$18.7M-0.1% | -$18.7M-0.1% | -$18.7M-9.0% | -$17.1M |
CLTS Cash Flow Statement
| Metric | Q3'22 | Q2'22 | Q1'22 | Q3'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0+100.0% | -$4K-404.1% | -$800-126.6% | $3K | $0+100.0% | -$6K+53.4% | -$13K+37.7% | -$21K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $0-100.0% | $4K+404.1% | $800 | $0+100.0% | -$3K-150.0% | $6K-53.4% | $13K-37.7% | $21K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CLTS Financial Ratios
| Metric | Q3'22 | Q2'22 | Q1'22 | Q3'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -0.5%+6.8pp | -7.3%-6.5pp | -0.8% | N/A | -12.7%-6.5pp | -6.1%+845.3pp | -851.4% | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | 0.01-0.5 | 0.47 |
| Debt-to-Equity | 0.100.0 | 0.100.0 | 0.100.0 | 0.09+2.0 | -1.90+0.1 | -2.03+0.1 | -2.10-0.2 | -1.87 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
Is Earth Life Scien profitable?
No, Earth Life Scien (CLTS) reported a net income of -$1.6M in fiscal year 2021.
What is Earth Life Scien's operating cash flow?
Earth Life Scien (CLTS) generated -$16K in operating cash flow during fiscal year 2021, representing cash generated from core business activities.
What are Earth Life Scien's total assets?
Earth Life Scien (CLTS) had $4.4M in total assets as of fiscal year 2021, including both current and long-term assets.
How many shares does Earth Life Scien have outstanding?
Earth Life Scien (CLTS) had 961M shares outstanding as of fiscal year 2021.
What is Earth Life Scien's debt-to-equity ratio?
Earth Life Scien (CLTS) had a debt-to-equity ratio of 0.09 as of fiscal year 2021, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Earth Life Scien's return on assets (ROA)?
Earth Life Scien (CLTS) had a return on assets of -35.8% for fiscal year 2021, measuring how efficiently the company uses its assets to generate profit.
What is Earth Life Scien's Piotroski F-Score?
Earth Life Scien (CLTS) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Earth Life Scien's earnings high quality?
Earth Life Scien (CLTS) has an earnings quality ratio of 0.01x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.